Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Natera, Inc. - Common Stock (NQ:NTRA)

369.39 +3.08 (+0.84%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 18, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,718,175
Open 365.78
Bid (Size) 363.50 (100)
Ask (Size) 368.50 (700)
Prev. Close 366.31
Today's Range 358.90 - 369.69
52wk Range 157.43 - 369.69
Shares Outstanding 139,693,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Natera CEO Steven Chapman Sells 1,698 Shares for $545,000 ↗
The sale was executed under a pre-arranged Rule 10b5-1 plan amended in March 2026, leaving Chapman with 98,199 directly held shares. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Largest MRD Study in Lung Cancer Highlights Strong Prognostic Value for SignateraTM
From Natera, Inc.
Via Business Wire

Performance

YTD
+61.4%
+61.4%
1 Month
+18.5%
+18.5%
3 Month
+59.6%
+59.6%
6 Month
+82.2%
+82.2%
1 Year
+110.6%
+110.6%

More News

Read More
News headline image
This Surprising Stock Has Been Stanley Druckenmiller's No. 1 Position for 8 Straight Quarters. Is It a No-Brainer Buy? ↗
Via The Motley Fool
News headline image
3 Reasons Investors Love Natera (NTRA)
Via StockStory
News headline image
Billionaire Stanley Druckenmiller Has 2 Megacap Stocks Worth Watching (Hint: His Top Holding Isn't Amazon, Alphabet, or Nvidia) ↗
Via The Motley Fool
Topics Artificial Intelligence Economy
News headline image
Here’s How Much You Would Have Made Owning Natera Stock In The Last 10 Years ↗
Via Benzinga
News headline image
New Publication Establishes Strong Clinical Validation of Signatera™ for MRD Assessment in Lymphoma
From Natera, Inc.
Via Business Wire
News headline image
3 Momentum Stocks to Own for Decades
Via StockStory
News headline image
Billionaire Stanley Druckenmiller Has Roughly 17% of His $5.2 Billion Duquesne Portfolio in Natera Stock. Is It Still a Buy After an 80% Run? ↗
Via The Motley Fool
News headline image
Natera and Susan G. Komen® Announce National Partnership to Accelerate Progress Against Breast Cancer
From Natera, Inc.
Via Business Wire
News headline image
Natera and Angiex Partner to Assess Response to Investigational Nuclear-Delivered Antibody-Drug Conjugate™ Using Signatera™
From Natera, Inc.
Via Business Wire
News headline image
3 Healthcare Stocks with Promising Prospects
Via StockStory
News headline image
Billionaire Stanley Druckenmiller Is Quietly Loading Up on Healthcare Stocks -- Here's What His New Positions Reveal ↗
Via The Motley Fool
News headline image
Billionaire Stanley Druckenmiller Bought Amazon and Alphabet in Q2. But His Single Biggest Holding Is Neither of Them -- and It's Not Nvidia Either. ↗
Via The Motley Fool
News headline image
3 Large-Cap Stocks Worth Investigating
Via StockStory
News headline image
2 Biotech Stocks Shaping Up for Major Breakouts ↗
Via MarketBeat
Topics ETFs
News headline image
Billionaire Stanley Druckenmiller's Top Holding Is Up 37% This Year. Is the Market Pricing in the Full Story? ↗
Via The Motley Fool
News headline image
Here's How Much $1000 Invested In Natera 10 Years Ago Would Be Worth Today ↗
Via Benzinga
News headline image
Q2 Rundown: Natera (NASDAQ:NTRA) Vs Other Biotechnology Stocks
Via StockStory
Topics Artificial Intelligence
News headline image
Natera Spotlights Record Signatera Volumes, Raises Outlook at Canaccord Conference ↗
Via MarketBeat
News headline image
Natera (NTRA) Q2 2026 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
5 Insightful Analyst Questions From Natera’s Q2 Earnings Call
Via StockStory
Topics Earnings
News headline image
Natera to Support New Clinical Trial Assessing ctDNA Dynamics with Latitude™ in Advanced Skin Cancers
From Natera, Inc.
Via Business Wire
News headline image
What to Know About This Natera Insider Transaction as Shares Surge to Record Highs ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
A Natera Co-Founder Sold 2,000 Shares From a Spouse's Account. Here's What It Suggests ↗
Via The Motley Fool
Topics Regulatory Compliance

Frequently Asked Questions

Is Natera, Inc. - Common Stock publicly traded?
Yes, Natera, Inc. - Common Stock is publicly traded.
What exchange does Natera, Inc. - Common Stock trade on?
Natera, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Natera, Inc. - Common Stock?
The ticker symbol for Natera, Inc. - Common Stock is NTRA on the Nasdaq Stock Market
What is the current price of Natera, Inc. - Common Stock?
The current price of Natera, Inc. - Common Stock is 369.39
When was Natera, Inc. - Common Stock last traded?
The last trade of Natera, Inc. - Common Stock was at 09/18/26 04:00 PM ET
What is the market capitalization of Natera, Inc. - Common Stock?
The market capitalization of Natera, Inc. - Common Stock is 51.60B
How many shares of Natera, Inc. - Common Stock are outstanding?
Natera, Inc. - Common Stock has 52B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.